Jan 23, 2025 · Library of Congress
Introduced in House
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
Sponsored by Diana Harshbarger (Republican-TN-1)
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.